Destabilization of vascular endothelial growth factor mRNA by the zinc-finger protein TIS11b

Oncogene

Volumn 23, Issue 53, 2004, Pages 8673-8680

  Ciais, Delphine ^a   Cherradi, Nadia ^a   Bailly, Sabine ^a   Grenier, Emilie ^a   Berra, Edurne ^b   Pouyssegur, Jacques ^b   LaMarre, Jonathan ^a,d   Feige, Jean Jacques ^a,c  

^a INSERM   (France)

^b CENTRE ANTOINE LACASSAGNE   (France)

^c CEA GRENOBLE   (France)

^d UNIVERSITY OF GUELPH   (Canada)

Author keywords

AU rich element; MRNA stability; TIS11b; VEGF

Indexed keywords

BUTYRATE RESPONSE FACTOR 1; CORTICOTROPIN; CYTOKINE; GROWTH FACTOR; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN D; HORMONE; PROTEIN; RIBONUCLEOPROTEIN; RNA BINDING PROTEIN; SMALL INTERFERING RNA; TIS11 PROTEIN; TIS11D PROTEIN; UNCLASSIFIED DRUG; VASCULOTROPIN; ZINC FINGER PROTEIN;

3' UNTRANSLATED REGION; ADRENAL CORTEX CELL; ANGIOGENESIS; ANIMAL CELL; ANTIANGIOGENIC ACTIVITY; ARTICLE; AU RICH MOTIF; BINDING SITE; CONSENSUS SEQUENCE; CONTROLLED STUDY; DNA TRANSFECTION; GENE; GENE EXPRESSION; GENE EXPRESSION REGULATION; HRNP L GENE; HUR GENE; HYPOXIA; IMMUNOPRECIPITATION; METHODOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN MOTIF; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; RNA STABILITY; TIS11B GENE; TRANSCRIPTION REGULATION; TUMOR ANGIOGENESIS; VEGF GENE;

3' UNTRANSLATED REGIONS; ANIMALS; BASE SEQUENCE; BINDING SITES; BUTYRATE RESPONSE FACTOR 1; CATTLE; DNA-BINDING PROTEINS; HALF-LIFE; IMMEDIATE-EARLY PROTEINS; MICE; MOLECULAR SEQUENCE DATA; NIH 3T3 CELLS; RATS; RNA INTERFERENCE; RNA STABILITY; RNA, MESSENGER; TRISTETRAPROLIN; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

ANIMALIA;

EID: 9644295900     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1207939     Document Type: Article

References (22)

1. Ariyoshi N, Kim YC, Artemenko I, Bhattacharyya KK and Jefcoate CR. (1998). J. Biol. Chem., 273, 7610-7619.
2. Brand C, Cherradi N, Defaye G, Chinn A, Chambaz EM, Feige JJ and Bailly S. (1998). J. Biol. Chem., 273, 6410-6416.
3. Carballo E, Cao H, Lai WS, Kennington EA, Campbell D and Blackshear PJ. (2001). J. Biol. Chem., 276, 42580-42587.
4. Carballo E, Lai WS and Blackshear PJ. (1998). Science, 281, 1001-1005.
5. Carballo E, Lai WS and Blackshear PJ. (2000). Blood, 95, 1891-1899.
6. Chen CY and Shyu AB. (1995). Trends Biochem. Sci., 20, 465-470.
7. Chinn AM, Ciais D, Bailly S, Chambaz E, LaMarre J and Feige JJ. (2002). Mol. Endocrinol., 16, 1417-1427.
8. Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K and Tuschl T. (2001). Nature, 411, 494-498.
9. Ferrara N, Gerber HP and LeCouter J. (2003). Nat. Med, 9, 669-676.
10. Goldberg-Cohen I, Furneaux H and Levy AP. (2002). J. Biol. Chem., 277, 13635-13640.
11. Laemmli UK. (1970). Nature, 227, 680-685.
12. Lai WS, Kennington EA and Blackshear PJ. (2003). Mol. Cell. Biol., 23, 3798-3812.
13. Levy AP, Levy NS and Goldberg MA. (1996). J. Biol. Chem., 271, 2746-2753.
14. Levy NS, Chung S, Furneaux H and Levy AP. (1998). J. Biol. Chem., 273, 6417-6423.
15. Negoescu A, Labat-Moleur F, Brambilla E, Chambaz EM and Feige JJ. (1994). Mol. Cell. Endocrinol., 105, 155-163.
16. Niranjanakumari S, Lasda E, Brazas R and Garcia-Blanco MA. (2002). Methods, 26, 182-190.
17. Pages G, Berra E, Milanini J, Levy AP and Pouyssegur J. (2000). J. Biol. Chem., 275, 26484-26491.
18. Raghavan A, Robison RL, McNabb J, Miller CR, Williams DA and Bohjanen PR. (2001). J. Biol. Chem., 276, 47958-47965.
19. Ross HJ, Sato N, Ueyama Y and Koeffler HP. (1991). Blood, 77, 1787-1795.
20. Shih SC and Claffey KP. (1999). J. Biol. Chem., 274, 1359-1365.
21. Stoecklin G, Gross B, Ming XF and Moroni C. (2003). Oncogene, 22, 3554-3561.
22. Stoecklin G, Ming XF, Looser R and Moroni C. (2000). Mol. Cell. Biol., 20, 3753-3763.